The influence of marijuana use on neurocognitive functioning in adolescents.
Marijuana use is common in adolescence, yet neural consequences have not been well delineated. This review seeks to ascertain whether heavy marijuana use in adolescence is associated with persistent neurocognitive abnormalities, and whether adolescents are more vulnerable to the impact of chronic marijuana use than adults. Among heavy marijuana using adults, neurocognitive deficits are apparent for several days following use, but may disappear after one month of abstinence. Studies of adolescent heavy users have identified impairments in learning and working memory up to six weeks after cessation, suggesting persisting effects, yet raise the possibility that abnormalities may remit with a longer duration of abstinence. Given ongoing neuromaturation during youth, adolescents may be more vulnerable to potential consequences of marijuana use than adults. This is supported by rodent models, which show greater memory impairments in animals exposed to cannabinoids as adolescents relative to those exposed as adults. Further, adult humans who initiated use in early adolescence show greater dysfunction than those who began use later. Together, these results suggest that adolescents are more vulnerable than adults to neurocognitive abnormalities associated with chronic heavy marijuana use; however, the impact of preexisting risk factors is unknown. Adolescents demonstrate persisting deficits related to heavy marijuana use for at least six weeks following discontinuation, particularly in the domains of learning, memory, and working memory. Further, adolescents appear more adversely affected by heavy use than adults. Longitudinal studies will help ascertain whether preexisting differences contribute to these abnormalities.
Schweinsburg
Alecia D
AD
VA San Diego Healthcare System, CA, USA.
Brown
Sandra A
SA
Tapert
Susan F
SF
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000818:Animals; D001288:Attention / Q000187:drug effects; D001921:Brain / Q000187:drug effects*; D002186:Cannabinoids / Q000633:toxicity*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007360:Intelligence / Q000187:drug effects; D007858:Learning / Q000187:drug effects*; D008279:Magnetic Resonance Imaging; D002189:Marijuana Abuse / Q000523:psychology* / Q000534:rehabilitation; D008568:Memory / Q000187:drug effects*; D008570:Memory, Short-Term / Q000187:drug effects; D009483:Neuropsychological Tests; D012377:Rodentia; D012907:Smoking / Q000009:adverse effects / Q000523:psychology; D013375:Substance Withdrawal Syndrome / Q000175:diagnosis / Q000523:psychology; D055815:Young Adult
D002186:Cannabinoids